Previous Close | 17.77 |
Open | 17.72 |
Bid | 17.26 x 100 |
Ask | 17.35 x 100 |
Day's Range | 17.28 - 17.72 |
52 Week Range | 15.65 - 28.75 |
Volume | |
Avg. Volume | 505,079 |
Market Cap | 601.306M |
Beta (5Y Monthly) | 0.75 |
PE Ratio (TTM) | 8.46 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BOCA RATON, Fla., April 24, 2024--Cross Country EVP, Chief Administrative Officer and General Counsel, Susan E. Ball, Named to Global Top 50 Corporate Counsel List.
BOCA RATON, Fla., April 10, 2024--Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2024 financial results on Wednesday, May 1, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, May 1, 2024.
BOCA RATON, Fla., February 23, 2024--Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) announced today that it is scheduled to participate in the Oppenheimer 34th Annual Healthcare Med-Tech & Services Conference taking place March 12-13, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations, will participate in virtual one-on-one investor meetings on Tuesday, March 12, 2024. No formal presentation will be made.